Nanoparticles-based drug delivery systems for cancer therapy offer great promising opportunity as they specifically target cancer cells, also increasing the bioavailability of anticancer drugs characterized by low water solubility. Platicur, [Pt(cur)(NH3)2](NO3), is a cis-diamine-platinum(II) complex linked to curcumin. In this work, an ultrasonication method, coupled with Layer by Layer technology, allows to obtain highly aqueous stable Platicur nanocolloids of about 100 nm. The visible light activated Platicur nanocolloids showed an increased drug release and antitumor activity on HeLa cells, with respect Platicur Nanocolloids in darkness. This occurrence could give very interesting insight for a selective activation of the nano-delivered Pt(II) complex and a possible side effects lowering. For the first time, the metabolic effects of Platicur nanocolloids photoactivation, in Hela cell line, have been investigated using a NMR based metabolomics approach coupled with statistical multivariate data analysis (MVA). The reported results highlight specific metabolic differences between photoactivated and non-photoactivated Platicur NCs treated HeLa cancer cells.

Visible light-activated water-soluble Platicur nanocolloids: photocytotoxicity and metabolomics studies in cancer cells

Federica De Castro
Primo
;
Viviana Vergaro
Secondo
;
Michele Benedetti;Francesca Baldassarre;Laura Del Coco;Francesco Paolo Fanizzi
Penultimo
;
Giuseppe Ciccarella
Ultimo
2020-01-01

Abstract

Nanoparticles-based drug delivery systems for cancer therapy offer great promising opportunity as they specifically target cancer cells, also increasing the bioavailability of anticancer drugs characterized by low water solubility. Platicur, [Pt(cur)(NH3)2](NO3), is a cis-diamine-platinum(II) complex linked to curcumin. In this work, an ultrasonication method, coupled with Layer by Layer technology, allows to obtain highly aqueous stable Platicur nanocolloids of about 100 nm. The visible light activated Platicur nanocolloids showed an increased drug release and antitumor activity on HeLa cells, with respect Platicur Nanocolloids in darkness. This occurrence could give very interesting insight for a selective activation of the nano-delivered Pt(II) complex and a possible side effects lowering. For the first time, the metabolic effects of Platicur nanocolloids photoactivation, in Hela cell line, have been investigated using a NMR based metabolomics approach coupled with statistical multivariate data analysis (MVA). The reported results highlight specific metabolic differences between photoactivated and non-photoactivated Platicur NCs treated HeLa cancer cells.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11587/442898
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 13
social impact